This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
spk00: Welcome to the Community Health Care Trust's 2024 second quarter earnings release conference call. On the call today, the company will discuss its 2024 second quarter financial results. It will also discuss progress made in various aspects of its business. Following the remarks, the phone lines will be opened for a question and answer session. The company's earnings release was distributed last evening and has also been posted on its website, www.chct.reit. The company wants to emphasize that some of the information that may be discussed on this call will be based on information as of today, July 31st, 2024, and may contain forward-looking statements that involve risk and uncertainty. Actual results may differ materially from those set forth in such statements. For a discussion of these risks and uncertainties, you should review the company's disclosures regarding forward-looking statements and its earnings release, as well as its risk factors and MD&A in its SEC filings. The company undertakes no obligation to update forward-looking statements, whether as a result of new information future developments or otherwise, except as may be required by law. During this call, the company will discuss GAAP and non-GAAP financial measures. A reconciliation between the two is available in its earnings release, which is posted on its website. Call participants are advised that this conference call is being recorded for playback purposes. An archive of the call will be made available on the company's investor relations website for approximately 30 days and is the property of the company. This call may not be recorded or otherwise reproduced or distributed without the company's prior written permission. Now, I would like to turn the call over to Dave Dupuy, CEO of Community Healthcare Trust.
spk05: Great, and good morning. Thank you for joining us today for our 2024 second quarter conference call. On the call with me today is Bill Monroe, our Chief Financial Officer, Leigh Ann Stack, our Chief Accounting Officer, and Tim Meyer, our EVP of Asset Management. Our earnings announcement and supplemental data report were released last night and furnished on Form 8K, along with our quarterly report on Form 10Q. In addition, an updated investor presentation was posted to our website last night. As disclosed in our filings, we determined that certain lease and interest payments from a geriatric inpatient psychiatric hospital tenant were not reasonably assured of collection. CHCT had six leases with the tenant, and it is the sole tenant in five of our properties, with one lease in a multi-tenanted property representing a total of approximately 79,000 square feet. As a geriatric psychiatric hospital operator, COVID had a significant impact on the tenant's business through 2022. And during this time, the tenant was in process of expanding locations, which led to a more pronounced impact. In 2023, the company approved census, installed a new revenue cycle management system, and made other operational improvements resulting in improved performance. Unfortunately, recent management changes resulted in a decline in census, staff turnover, and ultimately impacted the tenant's ability to consistently pay rent and interest. The tenant has hired a consulting team with significant behavioral operating experience to implement a turnaround plan and to stabilize the business. PHCT has previous experience with this consulting team, and we have confidence in their ability to make the necessary changes to improve operations. We are working closely with the tenant and the consultants to monitor and evaluate progress with the turnaround. Bill will discuss in more detail the financial impacts from this tenant, but let me review what we believe to be the unique features of this tenant relationship compared to the rest of our portfolio. Most importantly, this tenant is the only top ten tenant where we are also a lender. To improve transparency of our top tenants, we are now including in our supplemental data report An investor presentation, not just those tenants with greater than 4% of annualized rent, but a listing of all top 10 tenants. Another aspect of this tenant relationship that I mentioned earlier was that COVID significantly impacted this tenant, given its geriatric patient base. During time, we had also recently expanded locations. And because this tenant is a private founder-owned business, CHCT helped finance the tenant's expansion, leading to CHCT's $22.7 million in notes receivable across a term loan and revolving credit facility. This $22.7 million is by far our largest lending relationship, with our only other notes receivable currently outstanding consisting of a $4.5 million term loan to a long-term acute care and inpatient rehab hospital tenant, and a 2.2 million revolving credit facility to a substance use and eating disorder mental health provider tenant. To conclude, we believe we can work closely with this tenant over the coming quarters to enhance returns on this unique investment within the portfolio. As for other components of the business, our occupancy increased slightly from 92.3% to 92.6% during the quarter, and we continue to see good leasing activity in the portfolio. In addition, we have five properties or significant portions of those properties that are undergoing redevelopment or significant renovations with long-term tenants in place when the renovations or redevelopment is completed. Also, our weighted average remaining lease term increased from 6.9 years to 7.1 years. During the second quarter, we acquired an inpatient rehabilitation facility for a purchase price of $23.5 million. We entered into a new lease with a lease expiration in 2039 and anticipated annual return of approximately 9.1%. Subsequent to June 30th, we acquired one medical office building for a purchase price of approximately $6.2 million and expected returns of approximately 9.3%. The property is 100% leased with a lease expiration in 2027. Also, the company had signed definitive purchase and sale agreements for seven properties to be acquired after completion and occupancy for an aggregate expected investment of $169.5 million. The expected return on these investments should range from 9.1 to 9.75%. We expect to close on one of these properties in the fourth quarter of 2024, with the remaining six properties closing throughout 25, 26, and 27. And we continue to have many properties under review with term sheets out on properties with indicative returns of 9% to 10%. With our modest leverage levels, we anticipate having enough availability on our credit facilities and through our banking relationships to fund our acquisitions, and we expect to opportunistically utilize the ATM to strategically access the equity markets at favorable share prices. These traditional capital sources combined with proceeds from selected asset sales will provide sufficient capital for continued growth and attractive yields. To wrap up, we declared our dividend for the second quarter and raised it to 46.25 cents per common share. This equates to an annualized dividend of $1.85 per share. We are proud to have raised our dividend every quarter since the IPO. That takes care of the items I wanted to cover, so I will hand things off to Bill to discuss the numbers. Thank you, Dave. I will now provide more details on our second quarter financial performance. Let me start by detailing the impacts to our second quarter financials related to the geriatric inpatient behavioral hospital tenant that Dave described earlier. Rental income in the second quarter was negatively impacted by the reversal of $1.9 million of rent which includes approximately $900,000 of non-cash straight-line rent. Also, other operating interest in the second quarter was negatively impacted by the reversal of $1.4 million of interest. Combined, these items reduced total revenue in the second quarter by approximately $3.2 million to $27.5 million. Compared to the second quarter of 2023, total revenue declined by $294,000. And compared to the first quarter of 2024, total revenue declined by $1.8 million. It is important to note that of the $3.2 million impact to the second quarter of total revenue I just described, only approximately $1.5 million is the result of rental income and interest we expected to receive in the second quarter of 2024 from the geriatric inpatient behavioral hospital tenant, with the remaining amount resulting from one-time out-of-period adjustments to prior period amounts outstanding net of payments and security deposits. In addition to the reversals of rent and interest, we recorded an $11 million credit loss reserve on the $22.7 million notes receivable from the tenant. This credit loss reserve reduced net income and is based on an estimated value of the underlying collateral, which we will continue to monitor, but any future credit loss reserve reversals or increases will not impact FFO or AFFO. Moving to expenses, Property operating expenses decreased by $219,000 quarter over quarter to $5.6 million since the first quarter and higher seasonal expenses at several properties. General and administrative expenses increased by $206,000 quarter over quarter to $4.8 million as a result of increased professional fees. And interest expense increased by $924,000 quarter over quarter to $6 million because of increased borrowings under our revolving credit facility to fund the $23.5 million of acquisitions during the second quarter of 2024, as well as the $27.7 million of acquisitions during the final week of the first quarter of 2024. Moving to funds from operations, FFO was $11.6 million in the second quarter of 2024. On a quarter-over-quarter basis, FFO decreased from $14 million in the first quarter of 2024 And on a per-deleted common share basis over these periods, FFO declined from 53 cents to 43 cents per share. These decreases are primarily the result of the $3.2 million of reversals of rent and interest described earlier. Adjusted funds from operations, or ASFO, which adjusts for straight-line rent and stock-based compensation, totaled $14.3 million in the second quarter of 2024. On a quarter-over-quarter basis, AFFO decreased from $15.7 million in the first quarter of 2024, and on a per-diluted common share basis over these periods, AFFO declined from 59 cents to 53 cents per share. These decreases are also primarily the result of the $3.2 million of reversals of rent and interest described earlier. net of approximately $900,000 of straight line rent, which was added back, and that is why you see a smaller impact to AFFO quarter over quarter than FFO. I'll note that even at 53 cents, our dividend remains well covered with a current payout ratio of 87%. That concludes our prepared remarks. Borwin, we are now ready to begin the question and answer session.
spk00: Certainly. Thank you. We will now begin the question and answer session. To ask a question, you may press star then one on your touch-tone telephone. If you are using a speakerphone, please pick up your handset before pressing the keys. If at any time your question has been addressed and you would like to withdraw your question, please press star then two. At this time, we will pause momentarily to assemble our roster. The first question comes from the line of Rob Stevenson with Channy. Please go ahead.
spk03: Good morning, guys. Could you talk a little bit about how many facilities in total this tenant has and what percentage you represent of them and sort of how these properties are performing versus maybe some of their others in case they were to file bankruptcy and look to give up some leases?
spk05: Yeah, so, hey Rob, thanks for the question. We are, you know, this tenant has a total of six hospitals, and so the buildings that they have with us is really the entire, you know, makes up the entire complexion of their business. So, you know, obviously the reduction in census has been the catalyst for some of the issues that they've been having in paying rent and interest. But anyway, did that answer your question?
spk03: Yeah. I mean, I guess the follow-up to that would wind up being, you know, how much revenue would be at risk here if they were in bankruptcy from where we've adjusted to thus far? And are any of the acquisitions in the pipeline with this tenant?
spk05: There are no acquisitions in the pipeline with this tenant. You know, the run rate amount of rent and interest associated with this tenant is approximately a million and a half a quarter. So that gives you a sense. And look, like I said, we've got, you know, consultants in there that we've worked with before that's familiar with this tenant. And, you know, our intention and our purpose thought is that that consultant will be able to help affect the turnaround that should allow them to start paying us rent at some point. It's difficult when you're in the middle of the turnaround to identify exactly when that is, but we are on top of this on a weekly basis monitoring progress.
spk03: Okay. And I guess, how long were these guys on the watch list? I mean, was this a sort of slow process to get to here? Or was it basically, you know, a couple of weeks, you know, and it was like flipping a switch, just trying to get a sense as to, you know, these days, how quickly these problem assets are appearing on the radar screen, whether or not it's, you know, something that, you know, there's a little bit more warning for basically, you come in one day and find out that, you know, they're having much more difficulties than you imagined.
spk05: Well, you know, one of the things I mentioned in the prepared remarks, because this has been a relationship for the firm for a while, so for the last, you know, from 2020 to 2022 during COVID, they were very much on the watch list, just given the nature of the business and the geriatric patient base and the challenges they were having ramping up the two new hospitals that we had that we had financed. And so they were on the watch list then. They had fallen off the watch list in 2023, and the business was performing very, very well. Then with these management changes late in the fourth quarter of 2023, we started seeing some late rents and some concerns with regard to census and performance, and so they came back on the watch list in the first quarter. They made partial payments in the first quarter and second quarter, but ultimately it wasn't enough to make us comfortable that all of the rent was gonna be collectible, and so that's why we moved them to cash basis.
spk03: Okay, and speaking of the watch list, how significant is that overall today? And anybody else, any other of the top tenants on that list today?
spk05: None of the other top tenants are currently on our watch list. You know, the watch list is similar today in terms of numbers than it was before, but, you know, obviously very disappointing to us that such a large tenant on the heels of what we had to go through the Genesis care last year is having this issue and these problems. But, you know, again, we feel good about the top 10 list currently. We're very well diversified beyond, you know, these other tenants. And so we feel good about the portfolio overall.
spk03: Okay. And then just one last one for me. Bill, how should we be thinking about the 53 cents of AFFO per share going forward? I know that that didn't get adjusted as much as the FFO was. But is there other stuff that either has to come out of that or be added back to that in future quarters? Or is that still a ballpark run rate for where the company is today, given the reductions with this one tenant?
spk05: Yeah, I think until we see, you know, improvement from this tenant, we're kind of in the right ballpark. I mean, the short answer is of the, you know, charges we took in the second quarter that were out of period, you know, charges. You know, you'd say, you know, approximately $750,000, $800,000 of AFFO should kind of be added back on a run rate basis, you know, compared to where our second quarter AFFO was. Obviously, as we move forward, we don't provide guidance, but interest expense, G&A, other things, it will also be taken into account as far as what AFFO will be. But clearly, the biggest impetus to an increased quarter-over-quarter on an AFFO basis will be improved performance and payment of rent and interest from this tenant.
spk03: Okay. That's helpful, guys. Thank you. Appreciate the time this morning. Thanks, Rob.
spk00: Thanks. Thank you. The next question comes from Alexander Goldfarb with Piper Sandler. Please go ahead.
spk01: Hey, good morning down there. Dave, I mean, I don't, as you have this tenant, and obviously, as you said, it's on the heels of Genesis, clearly something you guys didn't need. But, you know, one, these were all deals that were done before you guys took over, not casting blame, but clearly, you know, these were deals done years ago, not recently. So as you look at the portfolio and at your underwriting, you know, what are some of the lessons learned from Genesis and now here that as you look at your acquisition pipeline and existing tenants, you go, hey, you know, maybe we want to kick these deals out or, hey, you know what, we have other tenants that look like, Genesis or this tenant in terms of payment history or coming up a little light in their envelope when they pay the monthly rent. What are some of the things that you've seen and reassessments of existing tenants and acquisition pipeline?
spk05: Thanks, Alex. That's a great question. I will say in the wake of Genesis Care in this latest situation, You know, we have tightened our underwriting standards. The bar is higher. I will also tell you, you won't see us land at these levels to a single tenant again. That just won't happen. So, you know, obviously COVID was a unique situation, and everyone who went through it, we all went through it, especially the geriatric population. it drove significant borrowings from this tenant and at the end of the day um you know any slip and census had an impact on their ability to pay rent and interest and so you know from our perspective we're just going to be more rigorous with our underwriting and you're just not going to see these same levels of loans to a single tenant going forward because you know honestly that is not in insane with our diversification strategy as a firm. So, and that's very important to us. So that, that is a core lesson here for sure.
spk01: But as far as, you know, it's not just the loan that went bad, it was the tenant as well. And certainly it happened with Genesis. So does this mean that you, you know, you want to shy away from doing portfolio deals and stick to single asset deals or like, how is this changing? And then also why even lend anything to a tenant? Why not just keep it a purely a rental relationship?
spk05: Well, every situation is unique. And so, you know, sometimes there are competitive reasons. Sometimes there are very good reasons for us wanting to lend as part of an overall relationship. And what I would say, Alex, relative to portfolio deals. Historically, we have been reluctant to do portfolio deals in a meaningful way. But, you know, going back to Genesis Care, look, you know, that was a portfolio deal. Ultimately, you know, it wasn't a fun process, and you're disappointed that the hold co. was overleveraged and didn't perform. But ultimately, the performance at our facilities largely worked out. And, you know, it wasn't a fun process. But at the end of the day, you know, it's important that we underwrite each individual market and each individual property because that is what is ultimately going to drive rent and interest payment to us, whether from that tenant or a new tenant. So I'm not going to say we won't do a portfolio deal because there could be opportunities for us to do portfolio deals. But our underlying standards are going to be more rigorous.
spk01: Okay, just final question is, obviously, the stock's taken a bit of a hit, you know, to the, you know, do you reconsider, you know, the committed acquisition pipeline? Or how does how does where the stock is now trading, change, you know, the the goal of getting the pipeline back up to sort of that 130 150 million a year?
spk05: Listen, we're very focused on looking at all sources of capital. We continue to have a modestly leveraged balance sheet. We don't think that this is going to impact in any way what we've committed to do in our pipeline. And actually, we recognize as a small REIT, even though we are definitely going to be judicious with our capital, Growth is what's going to drive our performance. From a share price perspective, it's all about driving ASFO and FFO. We're just going to be very strategic in how we do that. We've got other levers than just the stock. We can do some capital recycling in the portfolio. We can borrow just given our leverage levels and the support from our banks. overall, we feel very positive in our ability to access the various markets to be able to continue to fund our growth.
spk02: Thank you. Thanks, Alex. Thank you.
spk00: The next question comes from Michael Lewis with Truist. Please go ahead.
spk07: Great. Thank you. So Alex just asked one of the questions that I think is one of the more important questions right so this the stock over the last 12 months was already down you know 18 or 20 percent and i think investors were asking you know at what point is the cost of equity no longer acceptable to issue shares to fund new investments at nine handle cap rates um you know it's obviously this morning it's taken another leg down it's i know it's a tough question to answer you don't want to put yourself in a box but you know when does the cost of equity become prohibitive? Because I think there's a danger here, you know, if you lose access to kind of that capital or that spread over your investment yield. So I don't know what more you could say on that. Maybe you already answered it.
spk05: Well, you know, it is a tough one to answer. But what I would tell you is, you know, we're looking to make accretive acquisitions. And, you know, we And those acquisitions need to drive overall revenue and ASFO growth for the company. And so we're highly sensitive as shareholders in the company about doing a dilutive equity raise and doing that in the ATM. And so we're going to be very mindful of that. And as I just mentioned earlier with the prior question, Michael, I mean, we've got opportunities within the portfolio to do some capital recycling to fund some growth, and so we do have other tools in our toolbox that will allow us to continue to grow without putting pressure on the stock. We recognize that that's not good for us, and ultimately it's not good for driving AFFO growth. Bill, I don't know if you want to comment there. No, I agree.
spk07: Okay, thanks. And then You talked about your expectations to hopefully the consultant helps and the tenant gets paying again. In a worst-case scenario where the tenant doesn't recover, are these properties, do you think they're relatively easy to re-tenant or sell or what kind of the plan would be? I don't mean to jump right to the worst case, but I think it's important to kind of judge what that might look like.
spk05: Yeah, so, Michael, one of the benefits from having been in the healthcare services sector myself and Bill for a number of years is we know a lot of operators in this space, and obviously we have some tenants that are operators that would be interested in these assets. The short answer, without jumping to that scenario, is there are many potential buyers interested in these these psych hospitals and there is a a little bit of a scarcity value to these to these businesses and so you know again the business and these individual hospitals I think would be attractive to an individual potential buyer and Michael still I'll add that You know, we have not seen and we do not believe there's been a change in the competitive landscape in these local markets where this tenant operates, you know, such that it is more of an execution issue. And so I think that helps preserve, you know, what is the value of these properties as we think about it.
spk07: Okay. Because for whatever it's worth, I mean, we do see REITs and other healthcare sectors, you know, lose significant tenants and the stocks don't, take hits like this. I think it has to have to do with, you know, being able to reposition assets. But my last question, just on the acquisition pipeline, you know, I think the deal that you closed in the first quarter, you had already mentioned on the, or I'm sorry, closed in the second quarter, you had already mentioned on the first quarter call. So, you know, has there not been any, you know, new activity over the last few months? And, you know, does the pipeline Do you think you're still on target for your acquisition goals for the year?
spk05: You know, we have continued to be active, seen a number of deals. We've got term sheets outstanding, as I mentioned in the prepared remarks. You know, sometimes we've seen in the past where closings are a little bit slower in the third quarter, just the realities of summer and vacation schedules, etc., But we do think that hitting our acquisition target is certainly still achievable, the balance of the year. And like I said, I think we're still seeing good activity from an acquisition standpoint, which doesn't always translate into closed deals, but it's certainly better than not seeing the activity. So, yes, we still feel like that that's achievable. And, Michael, I'll note we did include that we closed a $6.2 million property early in the third quarter here. So it didn't show up in the second quarter closed numbers, but we did mention it in our investor presentation that we did close an additional property early this quarter, just this month.
spk02: Okay. Thank you.
spk00: Thank you. Ladies and gentlemen, if you have a question, please press star, then 1. Next question comes from Wes Galladay with RBC Capital Markets. Please go ahead.
spk04: Hey, good morning, guys. This is actually Baird Capital. When you look at the lease expiration schedule, you have $107 million of rent annually. Does that include the tenant that is having issues right now?
spk02: And is that a cash number? I'd have to look.
spk05: I would think that it would include those leases in the number, but those leases that we have with the tenant don't expire in the near term. Yeah, the lease maturities of the tenant we've been discussing is between 2030 and 2036, so no upcoming maturities with that tenant.
spk04: Okay, I just want to make sure the $107 million incorporates that. And then when you look at what they're paying on cash accounting now, did they pay anything in the second quarter? Just a little bit, not much.
spk05: Just some small payments. And, you know, we're not necessarily expecting to get meaningful payments in the third quarter either. I mean, they're in the middle of this turnaround. So, yeah.
spk04: Okay. And then when you look at the line of credit, the utilization is getting higher, but then you could probably issue another term loan. How are you looking at that?
spk02: Yeah.
spk05: We have $41 million available under our revolver at the end of the quarter. The next maturity is not until March of 2026, but typically what we do is when we get within a year or so of those maturities, look to term out those revolver borrowings. And so, you know, we anticipate, you know, taking a look at that and, you know, again, have had success with our bank group doing that historically.
spk02: And so, we continue to evaluate that.
spk04: Okay. Thanks for the time.
spk02: Thanks, Wes.
spk00: Thank you. The next question comes from Jim Kammer with Evercore. Please go ahead.
spk06: Good morning. Thank you. Do you have the ability under the lease with this tenant in question to replace them? Meaning they're in default. I presume they're not paying the rent, obviously. Why wait, in other words? And if these are desirable assets, try to parallel path and look for a replacement tenant or a new owner – I mean, pardon me, a new operator. Okay.
spk05: Hey, Jim, thanks for the question. Yes, we absolutely do have the ability to replace them. They're obviously in default of our lease, and we are taking multiple paths. We're not just kind of wed to the consultants, and we're looking at other options. But, you know, given the fact that this tenant, you know, has outstanding loans to us, and we think, you know, if you go back in 2023 and see how this tenant was able to perform and pay their rent and interest, you know, certainly from our perspective, we want to try to preserve options with this tenant. But, you know, I will say that they're on a short leash. And like I said, we've got a number of folks that we think could operate these facilities. And so we're, you know, obviously we're aligned. We want to make sure that we get a paying tenant in there. Hopefully it's this tenant. But if it's not, we'll evaluate others.
spk06: Great. Because I'm just trying to reconcile that with the prior comments that That's very helpful. Thanks. You know, you've taken basically a 50% reserve against the loan balance. And if these are, you know, this is basically the business entire network of hospitals, it could be saleable. Just trying to understand why such a draconian hit then on the receivable. If there's any additional color you can provide there, it seems inconsistent with the premise that these are saleable, marketable assets. Maybe just go and recycle them, sell it.
spk05: Yeah, no, listen, I hear you. It's just one of those processes you have to go through that CECL requires you to go through, and it's a pretty structured accounting process that we have to take. And so that's what we went through. And look, at the end of the day, you're trying to come up with a value for the business and be conservative given the current environment. And so that's kind of what you're seeing there in terms of the reserve. But there's no question. We think that there is value in the operations here. And, you know, we're trying to stabilize the business and make sure we can drive as much value from those operations as we can.
spk06: Great. So you worked a little bit with your accountants. And so CECL really did drive that determination. It was not a So in-house. Okay, perfect. That's helpful. Thank you. Thanks. Yeah. Thanks, Jim.
spk00: Thank you. Thank you. Ladies and gentlemen, this concludes our question and answer session. I would like to turn the conference back over to Dave Dupuy for any closing remarks.
spk05: Listen, thank you, operator, and thank you, everyone, for joining us this morning. We hope everyone has a good day and look forward to talking to you next quarter. Thank you.
Disclaimer